In ovarian cancers, a typical “cold” immune phenotype, PORCN inhibitors CGX-1321 suppressing Wnt/β-catenin signaling, has been confirmed to improve CD8+ T-cell levels in the omentum TME (143). The gene discussed is CD8A; the disease is ovarian cancer.